BioSapien
Developing MediChip, a 3D printed drug delivery platform for localized treatment administration.
About
Technology stack
detected 2026-06-14No comments yet. Be the first to share your take.
What does BioSapien do?
BioSapien is a biotechnology company developing MediChip, a localized cancer treatment solution. This bio-compatible patch delivers medication directly to tumors, aiming to reduce systemic chemotherapy side effects and improve patient quality of life. Their technology serves cancer patients by offering a more targeted and less disruptive treatment option.
How much funding has BioSapien raised?
BioSapien has raised a total of $1M in funding. The most recent round on record is Seed.
Where is BioSapien headquartered?
BioSapien is headquartered in San Jose, California, USA.
When was BioSapien founded?
BioSapien was founded in 2017.
What industry does BioSapien operate in?
BioSapien operates in Biotechnology, Medical Devices, 3D Printing, Biotech, MedTech, HealthTech.